ACCMF yields 16.58% · JNJ yields 2.13%● Live data
📍 ACCMF pulled ahead of the other in Year 1
Combined, ACCMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ACCMF + JNJ for your $10,000?
AAC Clyde Space AB (publ) primarily provides solutions and services to the small satellite market in Sweden, the United Kingdom, other European countries, the United States, Asia, and internationally. The company offers command and data handling, batteries, electrical power systems, laser and radio communications systems, solar arrays, lightweight structure solutions, and propulsion systems, as well as payloads, plug-and-play satellite attitude determination and control systems. It also involved in the provision of space as a service, which includes data subscription, data delivery, customer portal access, insurance, and data protection. In addition, the company operates EPIC spacecraft platform. It serves the government, commercial, and educational organizations. The company was formerly known as ÅAC Microtec AB (publ) and changed its name to AAC Clyde Space AB (publ) in November 2019. AAC Clyde Space AB (publ) was founded in 2005 and is headquartered in Uppsala, Sweden.
Full ACCMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.